Literature DB >> 25949949

Cancer therapy with phytochemicals: evidence from clinical studies.

Azar Hosseini1, Ahmad Ghorbani2.   

Abstract

Cancer is still one of the major causes of mortality in both developing and developed countries. At present, in spite of intensive interventions, a large number of patients suffer from poor prognosis. Therefore, the effort for finding new anticancer agents with better efficacy and lesser side effects has been continued. According to the traditional recommendations and experimental studies, numerous medicinal plants have been reported to have anticancer effect. Also antiproliferative, pro-apoptotic, anti-metastatic and anti-angiogenic effects of several phytochemicals have been shown in in vitro experiments or animal studies. However, only a small number have been tested in cancerous patients and limited evidence exists for their clinical effectiveness. Also, regarding some phytochemicals, only beneficial effects on cancer-related symptoms or on quality of life have been reported and no positive results exist for their antitumor actions. This review was focused on the phytochemicals whole beneficial effects on various types of cancer have been supported by clinical trials. Based on the literature review, curcumin, green tea, resveratrol and Viscum album were the satisfactory instances of clinical evidence for supporting their anticancer effects. The main findings of these phytochemicals were also summarized and discussed.

Entities:  

Keywords:  Cancer; Phytochemical; Plant; Tumor

Year:  2015        PMID: 25949949      PMCID: PMC4418057     

Source DB:  PubMed          Journal:  Avicenna J Phytomed        ISSN: 2228-7930


  76 in total

1.  The neurologic side effects of chemotherapeutic agents.

Authors:  Edward J Dropcho
Journal:  Continuum (Minneap Minn)       Date:  2011-02

Review 2.  The preclinical and clinical activity of aviscumine: a potential anticancer drug.

Authors:  Heinz Zwierzina; Lothar Bergmann; Heiner Fiebig; Steinar Aamdal; Patrick Schöffski; Klaus Witthohn; Hans Lentzen
Journal:  Eur J Cancer       Date:  2011-04-12       Impact factor: 9.162

3.  Efficacy and safety of Rhus verniciflua stokes extracts in patients with previously treated advanced non-small cell lung cancer.

Authors:  Seong Ha Cheon; Kyung Seok Kim; Sehyun Kim; Hyun Sik Jung; Won Cheol Choi; Wan Kyu Eo
Journal:  Forsch Komplementmed       Date:  2011-04-04

4.  A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma.

Authors:  Aminah Jatoi; Neil Ellison; Patrick A Burch; Jeff A Sloan; Shaker R Dakhil; Paul Novotny; Winston Tan; Tom R Fitch; Kendrith M Rowland; Charles Y F Young; Patrick J Flynn
Journal:  Cancer       Date:  2003-03-15       Impact factor: 6.860

5.  A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach.

Authors:  E Choan; Roanne Segal; Derek Jonker; Shawn Malone; Neil Reaume; Libni Eapen; Victor Gallant
Journal:  Urol Oncol       Date:  2005 Mar-Apr       Impact factor: 3.498

6.  Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study.

Authors:  Saverio Bettuzzi; Maurizio Brausi; Federica Rizzi; Giovanni Castagnetti; Giancarlo Peracchia; Arnaldo Corti
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

7.  A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer.

Authors:  Alejandra T Perez; Banu Arun; Debu Tripathy; Mary A Tagliaferri; Heather S Shaw; Gretchen G Kimmick; Isaac Cohen; Emma Shtivelman; Katherine A Caygill; Deborah Grady; Mark Schactman; Charles L Shapiro
Journal:  Breast Cancer Res Treat       Date:  2010-02       Impact factor: 4.872

8.  The standardised mistletoe extract PS76A2 improves QoL in patients with breast cancer receiving adjuvant CMF chemotherapy: a randomised, placebo-controlled, double-blind, multicentre clinical trial.

Authors:  V F Semiglasov; V V Stepula; A Dudov; W Lehmacher; U Mengs
Journal:  Anticancer Res       Date:  2004 Mar-Apr       Impact factor: 2.480

9.  Effects of red ginseng upon postoperative immunity and survival in patients with stage III gastric cancer.

Authors:  Sung Ock Suh; Matthew Kroh; Nam Ryeol Kim; Yong Geul Joh; Min Young Cho
Journal:  Am J Chin Med       Date:  2002       Impact factor: 4.667

10.  Flavonoids: A versatile source of anticancer drugs.

Authors:  Maheep K Chahar; Neelu Sharma; Mahabeer P Dobhal; Yogesh C Joshi
Journal:  Pharmacogn Rev       Date:  2011-01
View more
  62 in total

Review 1.  Mitochondria-Centric Review of Polyphenol Bioactivity in Cancer Models.

Authors:  Jan F Stevens; Johana S Revel; Claudia S Maier
Journal:  Antioxid Redox Signal       Date:  2017-12-11       Impact factor: 8.401

2.  Berberine reverses epithelial-mesenchymal transition and modulates histone methylation in osteosarcoma cells.

Authors:  Rutusmita Mishra; Sandip Nathani; Ritu Varshney; Debabrata Sircar; Partha Roy
Journal:  Mol Biol Rep       Date:  2020-10-19       Impact factor: 2.316

Review 3.  Decursin and decursinol angelate: molecular mechanism and therapeutic potential in inflammatory diseases.

Authors:  Adeeb Shehzad; Sajida Parveen; Munibah Qureshi; Fazli Subhan; Young Sup Lee
Journal:  Inflamm Res       Date:  2017-11-13       Impact factor: 4.575

4.  CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer.

Authors:  Sayantan Bhattacharyya; Vasanthakumar Sekar; Biswanath Majumder; Debapriya G Mehrotra; Samir Banerjee; Anup K Bhowmick; Neyaz Alam; Gautam K Mandal; Jaydip Biswas; Pradip K Majumder; Nabendu Murmu
Journal:  Cell Oncol (Dordr)       Date:  2016-12-30       Impact factor: 6.730

5.  Cutting down on lung cancer: Ecliptasaponin A is a novel therapeutic agent.

Authors:  Mirja Rotinen; Ignacio Encío
Journal:  Ann Transl Med       Date:  2020-07

Review 6.  Phytochemicals: Current strategies for treating breast cancer.

Authors:  Bridg'ette B Israel; Syreeta L Tilghman; Kitani Parker-Lemieux; Florastina Payton-Stewart
Journal:  Oncol Lett       Date:  2018-03-20       Impact factor: 2.967

7.  Curcumin directly inhibits the transport activity of GLUT1.

Authors:  Leesha K Gunnink; Ola D Alabi; Benjamin D Kuiper; Stephen M Gunnink; Sam J Schuiteman; Lauren E Strohbehn; Kathryn E Hamilton; Kathryn E Wrobel; Larry L Louters
Journal:  Biochimie       Date:  2016-03-31       Impact factor: 4.079

Review 8.  Antioxidants in liver health.

Authors:  Sael Casas-Grajales; Pablo Muriel
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

9.  Tangeretin derivative, 5-acetyloxy-6,7,8,4'-tetramethoxyflavone induces G2/M arrest, apoptosis and autophagy in human non-small cell lung cancer cells in vitro and in vivo.

Authors:  Yi Rong Li; Shiming Li; Chi-Tang Ho; Ya-Han Chang; Kok-Tong Tan; Ting-Wen Chung; Bing-Yen Wang; Yu-Kuo Chen; Chi-Chen Lin
Journal:  Cancer Biol Ther       Date:  2016       Impact factor: 4.742

Review 10.  Piperine: role in prevention and progression of cancer.

Authors:  Mariia Zadorozhna; Tiziana Tataranni; Domenica Mangieri
Journal:  Mol Biol Rep       Date:  2019-07-04       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.